Information Provided By: 
Fly News Breaks for November 19, 2019
PGNY
Nov 19, 2019 | 07:31 EDT
JPMorgan analyst Anne Samuel initiated coverage of Progyny with an Overweight rating and $26 price target. The company is a data-driven fertility benefits provider with a differentiated model in a large and growing fertility market, Samuel tells investors in a research note. Further, with 80 clients today, Progyny is "minimally penetrated" relative to the 8,000 self-insured employers it views as addressable, adds the analyst. She believes the company's EBTIDA growth should support the valuation over time.
News For PGNY From the Last 2 Days
There are no results for your query PGNY
